Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02627066 · ClinicalTrials.gov registry record · NA

Optimizing Cardiovascular Health and Physical Function in Hemodialysis Patients Through Volume Control and Exercise

A NA study, sponsored by University of Illinois at Urbana-Champaign.

Completed
Registry status
NA
Development phase
37
Enrollment target

NCT02627066: Completed NA study, sponsored by University of Illinois at Urbana-Champaign.

NCT02627066 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 37 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02627066, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.

COMPLETED
Registry status
NA
Development phase
37 participants
Enrollment target

Study Summary

This is a 12 month randomized clinical trial in which patients with renal failure undergoing maintenance hemodialysis (MHD) therapy will be placed on a volume reduction protocol that includes a novel low sodium dietary education program mediated by a lifestyle interventionist with significant collaboration from the existing clinic staff. Participating patients will be randomized to receive: 1) the volume control protocol alone (VC), or 2) the volume control protocol + physical activity and exercise counseling (VCE) from the lifestyle interventionist (LI). A research dietitian (RD), working in collaboration with the existing clinic RD, will develop a program to immerse clinics in a culture of sodium restriction. The research RD will train the LI and other clinic staff (nurses, technicians, etc) to help disseminate this program, modeled after the clinic-wide dissemination approach used in Izmir, Turkey (Dr. Ercan Ok). In addition, the LI will provide exercise and physical activity counseling to the participants randomized to the exercise group, utilizing a SCT-based approach. The Investigators hypothesize that mean arterial pressure will be reduced, and physical function increased, in all patients at 12 months, but the magnitude of these improvements will be greater in the VCE group.

Primary Outcome

Bioelectrical Impedance Determined Extracellular Hydration status

Interventions

  • BEHAVIORAL Volume Control
  • BEHAVIORAL Volume Control + Exercise

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2015-12
Est. Completion 2018-07
Phase NA

What the finished NCT02627066 record still lists

NCT02627066 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Volume Control is the first listed.

NCT02627066 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02627066 about?

NCT02627066 is a clinical study titled "Optimizing Cardiovascular Health and Physical Function in Hemodialysis Patients Through Volume Control and Exercise". This is a 12 month randomized clinical trial in which patients with renal failure undergoing maintenance hemodialysis (MHD) therapy will be placed on a volume reduction protocol that includes a novel low sodium dietary education program mediated by a lifestyle interventionist with significant collab...

What is the current status of trial NCT02627066?

This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2015-12. Estimated completion is 2018-07.

What interventions are being tested in trial NCT02627066?

The interventions under investigation include: Volume Control (BEHAVIORAL), Volume Control + Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT02627066?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02627066's enrollment target sits among peer trials

37 1540th of 2000 higher than 460 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02800486 · 37 participants · Phase 2

    Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

  • NCT03173937 · 37 participants · Phase 1

    Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

  • NCT03295227 · 37 participants · Phase 1

    Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

  • NCT03401047 · 37 participants · Early Phase 1

    Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02627066, the US trial registry maintained by the National Library of Medicine. NCT02627066 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.